Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Shalvata Mental Health Center
ClinicalTrials.gov Identifier:
NCT00445926
First received: March 8, 2007
Last updated: May 5, 2010
Last verified: May 2010
  Purpose

The study evaluates the feasibility of using a 4 week stimulation protocol with the deep TMS H-coils for the treatment of negative symptoms and cognitive deficit in schizophrenia patients


Condition Intervention Phase
Schizophrenia
Device: deep TMS H-coil
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Deep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia

Resource links provided by NLM:


Further study details as provided by Shalvata Mental Health Center:

Study Start Date: July 2006
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM IV Diagnosis of Schizophrenia
  • PANNS Negative > 21

Exclusion Criteria:

  • risk factors for convulsions
  • PANNS positive > 24
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00445926

Locations
Israel
Shalvata MHC
Hod Hasharon, Israel
Sponsors and Collaborators
Shalvata Mental Health Center
Investigators
Principal Investigator: Eiran V Harel, MD Shalvata MHC
  More Information

No publications provided

Responsible Party: Hilik Levkovitz, shalvataMHC
ClinicalTrials.gov Identifier: NCT00445926     History of Changes
Other Study ID Numbers: SH-40206
Study First Received: March 8, 2007
Last Updated: May 5, 2010
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on October 19, 2014